Sort   by:  
 Page size 
UnknownIdentification and Evaluation of Novel Protective Antigens for the Development of a Candidate Tuberculosis Subunit Vaccine.
Not available
S-EPMC6013653 | biostudies-literature
ProteomicsMass spectrometry of circulating antigens products isolated from sera of mice infected with Toxoplasma gondii tachyzoites
Toxoplasma gondii is a ubiquitous apicomplexan protozoan parasite that can infect all warm-blooded animals and lead to toxoplasmosis. Discovering efficient methods for diagnosing T. gondii infection and developing vaccine candidates are essential for controlling this disease. Circulating antigens (C...
ORGANISM(S): Toxoplasma gondii RH 
2021-01-04 | PXD021938 | Pride
Proteomics Toxoplasma gondii Circulating antigens Diagnostic candidates Acute infection Vaccine 
GenomicsProtective heterologous T cell immunity in COVID-19 induced by MMR and Tdap vaccine antigens
Protective heterologous T cell immunity in COVID-19 induced by MMR and Tdap vaccine antigens
PRJNA750464 | ENA
TranscriptomicsActivity of the Bacillus anthracis 20 kDa protective antigen component
Edema factor of anthrax binds to the protective antigen (PA83) which cleaves to PA63 and PA20. The role of PA20 was examined using highthroughput gene expression analysis of human peripheral blood mononuclear cells (PBMC) exposed to PA20. Keywords: Toxicity determination PBMC obtained from differe...
ORGANISM(S): Homo sapiens 
2008-08-26 | E-GEOD-12533 | biostudies-arrayexpress
ProteomicsA proteomic approach to identify vaccine candidates based on host cell attachment provides a novel protective Pseudomonas aeruginosa vaccine antigen: cell division protein, FtsZ
Pseudomonas aeruginosa is an opportunistic Gram negative pathogen that causes severe nosocomial infections in susceptible individuals due to the emergence of multi-drug resistant strains. There are no approved vaccines against P. aeruginosa infections nor candidates in active clinical development, h...
ORGANISM(S): Pseudomonas aeruginosa PA14 Bacteria 
2025-05-07 | PXD055823 | Pride
Antigens Pseudomonas aeruginosa Vaccine 
TranscriptomicsIdentification of antigens presented by MHC for vaccines against tuberculosis
The immune response against tuberculosis relies, at least in part, on CD4+ T cells. Protective vaccines require the induction of antigen-specific CD4+ T cells via mycobacterial peptides presented by MHC class-II in infected macrophages. We have purified MHC class-I and MHC-II peptides and analysed t...
ORGANISM(S): Mycobacterium tuberculosis variant bovis BCG 
2020-01-08 | E-MTAB-8057 | biostudies-arrayexpress
ProteomicsImmunomic identification of antigens
Immunomic screening of mice immune sera with different protection efficiencies against the whole P. yoelii 17X parasite proteome was performed to identify the repertoire of antigens recognized by those sera. The calculation of weighted scores reflecting the likelihood of protection of each antigens ...
ORGANISM(S): Plasmodium yoelii 17X 
2019-02-15 | PXD010567 | Pride
Malaria Immunoprecipitation 2d western blot Empai Lc-ms/ms 
UnknownVaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines.
Not available
S-EPMC1780059 | biostudies-literature
UnknownIsolation of recombinant protective Helicobacter pylori antigens.
Not available
S-EPMC96799 | biostudies-literature
UnknownGenetic mapping identifies novel highly protective antigens for an apicomplexan parasite.
Not available
S-EPMC3037358 | biostudies-literature
Sort   by:  
 Page size